Kyle P. Bransfield is Founder and CEO of Union Acquisition Group and leads its SPAC and Private Capital Businesses across multiple strategies.Mr. Bransfield serves as an Independent Director of Moolec Science (Nasdaq: MLEC) and Procaps Group (NASDAQ: PROC), and was formerly an Independent Director of Bioceres Crop Solutions (NYSE: BIOX), CEO and Director of Union Acquisition Corp. (NYSE: LTN) and CEO and Director of Union Acquisition Corp. II (Nasdaq: LATN).Mr. Bransfield has over 15 years of experience in public markets investing and SPAC management, and direct equity and debt private markets principal investing, capital raising, and investment banking. In addition to running Union Acquisition Group, Kyle established a SPAC asset management and investment banking business at EXOS Technology Financial Partners in partnership with former Credit Suisse CEO Brady Dougan and spent five years at Atlantic Pacific Capital managing the firm's global direct private placement and structured investment activities. Prior to joining Atlantic-Pacific, Kyle was an investment banker in Sagent Advisors’ Private Financing Solutions Group. Prior to Sagent, Mr. Bransfield spent over six years as a Principal and General Partner at CS Capital Partners, a Philadelphia-based multi-family office focused on alternatives. In his role he co-managed a portfolio of direct investments, served as an observer to several boards of directors, and fulfilled operating roles within portfolio companies. Kyle began his career in the Mergers & Acquisitions Group at Stifel Nicolaus Weisel and earned a B.S. in Business Administration from American University.